Developing a drug to treat dementia

Palliative therapies are likely to precede disease-modifying agents by years or decades, but these earlydrugs will provide the tools for future medical research, writes Professor Peter Stonier.
Author/s: Peter Stonier

For the full article please see the PDF download linked to the right. The full JDC archive is available if you subscribe.